Dupixent (dupilumab) has been hailed as a breakthrough medication for conditions like eczema, asthma, and chronic rhinosinusitis/sinusitis. However, recent evidence suggests the manufacturers may have failed to adequately warn patients and doctors about the potential risk of developing cancer, specifically cutaneous T-cell lymphoma (CTCL), after taking this medication. If you or a loved one developed cutaneous T-cell lymphoma after treatment with this drug, you may need the assistance of a Dupixent lawyer, and Phillips Law Group may be able to help.
Potential Link Between Dupixent Use and Developing T-Cell Lymphoma
A report published in the Journal of the American Academy of Dermatology (JAAD) in June 2025 found that “Cases of dupilumab treatment followed by cutaneous T-cell lymphoma (CTCL) diagnosis have been reported since dupilumab was approved for moderate-to-severe atopic dermatitis (AD) in 2017,” but that, “it may reflect dupilumab unmasking an underlying CTCL, dupilumab promoting lymphoid-reaction/CTCL under IL-13/IL-4 blockade, or CTCL developing in patients with advanced long-standing AD, regardless of treatment.”
However, another report published in the Journal of the American Academy of Dermatology in 2024 looked into the risk of CTCL after dupilumab use in patients with atopic dermatitis and found “an increased risk of CTCL was found in the cohort of AD patients who used dupilumab.” And there are other reports suggesting a link as well.
Ultimately, there is evidence that there could be a higher risk of developing CTCL after a patient takes Dupixent, and if you or a loved one were prescribed Dupixent and subsequently received a cancer diagnosis without this being a risk you were fully informed of, you deserve answers, justice, and compensation. Our team is here to assist you and discuss your legal options.
Work with Phillips Law Group
Our firm is investigating claims from individuals across the nation who believe their T-cell lymphoma was caused by this potentially dangerous drug. Phillips Law Group is adept at building robust litigation strategies to hold powerful pharmaceutical corporations accountable for their alleged failure to warn the public of severe side effects of drugs, and we want to get to the bottom of whether or not the manufacturers behind this medicine knew of the potential risks and didn’t warn patients appropriately.
We know the devastating impact of any cancer diagnosis, and if you or someone you love potentially received such a diagnosis because of taking a drug you believed would improve your health, not hurt it, you deserve justice. We have the resources and experience to aggressively pursue the compensation you may need for medical bills, pain and suffering, lost quality of life, and more.
Phillips Law Group has served our clients for more than 30 years, and we have secured more than $2 billion in settlements in that time. We believe we may be the right choice to partner with on a Dupixent lawsuit, and if we can’t assist you, we may be able to refer you to a firm that can.
Contact our dedicated personal injury lawsuit attorneys immediately for a free, confidential, and no-obligation case evaluation. You owe us nothing unless we take on your case and win it.
Let us fight for your rights while you focus on your health. Call 602-222-2222 or fill out the form on this page to get in touch now.
Available 24/7